Cytek Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Cytek Biosciences Stock Summary

Cytek Biosciences competes with Orthopediatrics Corp, Electromed, Pulmonx Corp, Rxsight, and Axogen. Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California. Cytek Biosciences operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 555 people.

Cytek Biosciences Key Financial Ratios

Cytek Biosciences Key Balance Sheet Accounts

Cytek Biosciences Key Income Statement Accounts

Cytek Biosciences Key Cash Accounts

Cytek Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cytek Biosciences's current stock value. Our valuation model uses many indicators to compare Cytek Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cytek Biosciences competition to find correlations between indicators driving Cytek Biosciences's intrinsic value. More Info.Cytek Biosciences is rated third in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Cytek Biosciences' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cytek Biosciences' earnings, one of the primary drivers of an investment's value.

Cytek Biosciences' Earnings Breakdown by Geography

Cytek Biosciences Systematic Risk

Today, most investors in Cytek Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cytek Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Cytek Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Cytek Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cytek Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cytek Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Cytek Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cytek Biosciences's daily price indicators and compare them against related drivers.

When running Cytek Biosciences' price analysis, check to measure Cytek Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytek Biosciences is operating at the current time. Most of Cytek Biosciences' value examination focuses on studying past and present price action to predict the probability of Cytek Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytek Biosciences' price. Additionally, you may evaluate how the addition of Cytek Biosciences to your portfolios can decrease your overall portfolio volatility.